Stockreport

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it has secured $200 million in committed capital [Read more]